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Abstract
AIM: To investigate the effects of four probiotic bac-
teria and their combination on human mast cell gene 
expression using microarray analysis.
METHODS: Human peripheral-blood-derived mast 
cells were stimulated with Lactobacillus rhamnosus  (L. 
rhamnosus) GG (LGG®), L. rhamnosus  Lc705 (Lc705), 
Propionibacterium freudenreichii  ssp. shermanii  JS (PJS) 
and Bifidobacterium animalis  ssp. lactis  Bb12 (Bb12) 
and their combination for 3 or 24 h, and were sub-
jected to global microarray analysis using an Affymetrix 
GeneChip® Human Genome U133 Plus 2.0 Array. The 
gene expression differences between unstimulated and 
bacteria-stimulated samples were further analyzed with 
GOrilla Gene Enrichment Analysis and Visualization Tool 
and MeV Multiexperiment Viewer-tool.
RESULTS: LGG and Lc705 were observed to suppress 
genes that encoded allergy-related high-affinity IgE re-
ceptor subunits α and γ (FCER1A and FCER1G, respec-
tively) and histamine H4 receptor. LGG, Lc705 and the 
combination of four probiotics had the strongest effect 
on the expression of genes involved in mast cell im-
mune system regulation, and on several genes that en-
coded proteins with a pro-inflammatory impact, such as 
interleukin (IL)-8 and tumour necrosis factor alpha. Also 
genes that encoded proteins with anti-inflammatory 
functions, such as IL-10, were upregulated.
CONCLUSION: Certain probiotic bacteria might diminish 
mast cell allergy-related activation by downregulation of 
the expression of high-affinity IgE and histamine recep-
tor genes, and by inducing a pro-inflammatory response.
© 2011 Baishideng. All rights reserved.
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INTRODUCTION
Mast cells are multifunctional regulator cells that are locat-
ed at strategic host-environment interfaces including skin, 
vascular barriers and gastrointestinal tract, where they 
encounter antigens and pathogens, as well as commen-
sal microbes. In the healthy intestinal mucosa, mast cells 
constitute 2%-3% of  the cells of  the lamina propria[1]. 
Mast cells are very heterogeneous cells that are tradition-
ally classified by the content of  their specific proteases 
tryptase and chymase. A mast cell subtype that contains 
only tryptase (MCT) is predominant in the lung and intes-
tine, whereas mast cells that contain tryptase and chymase 
(MCTC) are prevalent in the skin and conjunctiva[2]. Mast 
cell subtypes can even vary between different parts of  the 
same organ. Thus, MCT cells are enriched in the mucosal 
layer of  the intestine but MCTC cells outnumber them in 
the intestinal submucosa. However, this classification is 
thought to be interchangeable and can be shaped accord-
ing to the microenvironment of  the cells[3]. 
Mast cells participate in a variety of  physiological 
functions, such as epithelial secretion and permeability, 
blood flow, peristalsis, neuroimmune interactions, and 
wound healing. One significant task for mast cells is host 
defence against pathogenic microbes. By secreting several 
mediators including histamine, proteases, lipid mediators 
and pro- and anti-inflammatory cytokines, mast cells regu-
late the immune system and interact with other immune 
cells[4]. The multifunctionality of  mast cells can explain 
why they are also involved in the pathogenesis of  many 
inflammatory diseases, such as allergy. The number of  
mast cells and the amount of  mast-cell-derived mediators, 
such as histamine, which is the key mediator in allergy, are 
increased at sites of  allergic inflammation. The released 
mediators induce mucus and electrolyte secretion, smooth 
muscle contraction, nerve-cell activation and other symp-
toms common in allergic reactions[5]. The regulation of  
mast-cell mediators is complex. The best characterized 
mechanism of  mast cell activation is high-affinity IgE 
receptor (FcεR1)-mediated activation[6]. IgE-receptor ag-
gregation induces multiple signaling pathways that control 
the secretion of  allergy-related mediators, such as hista-
mine and leukotrienes, and the induction of  T helper cell 
2 (Th2) type cytokine and tumor necrosis factor (TNF) 
gene transcription[7]. The inflammatory effects of  the 
released histamine are mediated by histamine receptors 
H1-H4[8]. However, some of  the mast cell mediators, in-
cluding interleukin (IL)-10 and histamine[9] can have anti-
inflammatory effects and decrease inflammation[10]. 
Probiotics are defined as live microbes that have 
beneficial effects on the host’s health when administered 
in adequate amounts[11]. In clinical intervention studies, 
certain probiotics have been documented to be effective 
in the prevention and treatment of  various clinical condi-
tions. The most promising results of  the health effects of  
probiotics have been discovered in studies of  diarrhea[12], 
allergy[13], irritable bowel syndrome (IBS)[14,15], and respi-
ratory infections[16,17]. The effects of  probiotics are sug-
gested to be strain-specific, although one strain can have 
multiple influences[18]. In the treatment of  a complex and 
heterogeneous condition such as IBS, the use of  combi-
nations of  different strains of  probiotics can have advan-
tages over using a single strain[14]. The most investigated 
and used probiotic genera are Lactobacillus and Bifidobacte-
rium. Lactobacillus strains have been effective in beneficially 
modulating commensal microbes and inhibiting pathogen 
adhesion to gut mucosa. Lactobacillus and Bifidobacterium 
have been shown to produce antimicrobial agents and to 
alleviate symptoms of  allergy[19]. Dairy Propionibacterium, 
which has been observed to exclude pathogenic microbes 
from gut mucosa[20], has also been used as a probiotic. 
Evidence from two clinical trials performed with the 
combination of  four probiotic bacteria, i.e. Lactobacillus 
rhamnosus (L. rhamnosus) GG (LGG), L. rhamnosus Lc705 
(Lc705), Propionibacterium freudenreichii ssp. shermanii JS (PJS) 
and Bifidobacterium animalis ssp. lactis Bb12 (Bb12), suggests 
that the consumption of  such combination alleviates the 
symptoms in IBS patients[14,21]. As mast cells are believed 
to be important in regulating intestinal immunity and per-
haps also intestinal sensory functions, we chose to study 
the effects of  the above probiotic combination and each 
bacterium alone on the global gene expression of  primary 
peripheral-blood-derived human mast cells.
MATERIALS AND METHODS
Cell culture
Freshly collected buffy coats from healthy adult blood 
donors were provided by the Finnish Red Cross Blood 
Transfusion Service (Helsinki, Finland). The health of  the 
subjects for blood donation is strictly controlled. The do-
nors must be 18-65 years of  age, free of  infections includ-
ing HIV, hepatitis B and C, and free of  allergic symptoms 
and most chronic illnesses including autoimmune diseases. 
Mononuclear cells were purified from heparinized blood 
by Ficoll-Paque™ Plus (GE Healthcare, Uppsala, Swe-
den) density gradient centrifugation. Mast cell precursor 
cells were isolated by positive immunomagnetic selection 
using indirect CD34 MicroBead Kit and MACS® separa-
tion columns (Miltenyi Biotec, Bergish Gladbach, Ger-
many) according to the manufacturer’s instructions. After 
selection, the CD34+ cells were cultured for 9-11 wk in 
serum-free Stem Span™ cell culture medium (Stem Cell 
Technologies, Vancouver, Canada) supplemented with 
penicillin and streptomycin (GIBCO BRL, Grand Island, 
NY, USA), human recombinant stem cell factor (SCF; 
Peprotech, Rocky Hill, NJ, USA), IL-3 (Peprotech), IL-9 
(Peprotech), IL-6 (Peprotech) and human low-density 
lipoprotein, as previously described[22]. Cultured mast cells 
were phenotypically and functionally similar to mature 
MCTC cells as measured by c-kit and IgE receptor (FcεR1) 
expression, and the presence of  chymase, tryptase, hepa-
rin and histamine in their granules, as described previously 
in detail[23].
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Bacterial strains
L. rhamnosus GG (ATCC 53103), L. rhamnosus Lc705 (DSM 
7061), P. freudenreichii ssp. shermanii JS (DSM 7067) and 
B. animalis ssp. lactis Bb12 (DSM 15954) were provided 
by Valio Research Centre (Helsinki, Finland). LGG and 
Lc705 were grown as previously described[24]. PJS was 
grown under optimized aerobic conditions at 30℃ in whey 
broth (Valio) twice for 2 d at a concentration of  2%. Bb12 
was grown under anaerobic conditions at 37℃ in de Man, 
Rogosa and Sharpe (MRS) broth enriched with 5 g/L 
L-cysteine hydrochloride monohydrate (Merck, Darm-
stadt, Germany) three times for 17-18 h at a concentra-
tion of  2%[25]. LGG, Lc705, PJS and Bb12 were grown 
to logarithmic growth phase and the number of  bacteria 
was determined by counting in a Petroff-Hauser counting 
chamber. Chlamydia pneumoniae isolate Kajaani 6 (Cpn) was 
used as a reference strain, and was obtained from the Na-
tional Institute for Health and Welfare (Helsinki, Finland) 
and was propagated as described previously[22].
Mast-cell stimulation with bacteria
After differentiation, mast cells were collected and re-
suspended in fresh Stem Span™ medium that contained 
antibiotics and SCF as described above. Single live bacte-
rial strains were added to the cell culture in a bacterium-
to-cell ratio of  5:1 based on preliminary experiments (data 
not shown). When the stimulation was performed with 
the combination of  bacteria, each of  the four strains was 
dosed in a bacterium-to-cell ratio of  1.25:1, thus the total 
bacterium-to-cell ratio of  the combination was 5:1. The 
cells were incubated with bacteria for 3 or 24 h at 37℃ 
in 5% CO2. After incubation, mast cells were separated 
from the medium by centrifugation, and the medium was 
aliquoted and stored at -20℃. The cells were washed free 
of  bacteria, lysed and homogenized in RLT buffer (Qia-
gen, Valencia, CA, USA) and stored at -70℃ before RNA 
isolation. All experiments were performed with mast cells 
obtained from three different blood donors. For analysis, 
the cells from different donors of  each experiment were 
pooled. 
RNA isolation and microarray
Total RNA was isolated from the cell lysates using 
RNeasy Mini Kit (Qiagen) according to the protocol pro-
vided by the manufacturer. Microarray experiments were 
performed at Biomedicum Genomics (Helsinki, Finland) 
using an Affymetrix GeneChip® Human Genome U133 
Plus 2.0 Array (Affymetrix, Santa Clara, CA, USA). In-
tegrity and purity of  the RNA were verified with Agilent 
2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA, 
USA). Total RNA was prepared and hybridized using the 
two-cycle protocol of  the GeneChip® Expression Analy-
sis kit (Affymetrix) according to the manufacturer’s rec-
ommendations. Double-stranded cDNA was synthesized 
from total RNA. Next, biotin-labeled cRNA was tran-
scribed from the cDNA, and the cRNA was fragmented 
and hybridized. The hybridization reactions were scanned 
using a GeneChip Scanner 3000 (Affymetrix).
Microarray analysis
The robust multiarray averaging algorithm[26] in the Bio-
conductor simpleaffy package[27,28] was used to calculate 
expression estimates from GeneChip signal intensity data. 
To provide better precision and accuracy and to overcome 
interpretation problems related to conflicting id gene refer-
ences[27], an updated probe set definition was used[29], based 
on Ensemble gene information. In contrast to the default 
Affymetrix chip description file with 54 675 probe sets, the 
used custom chip description file (version 11.0.1) contained 
17 492 unique Ensemble gene probe sets. The significance 
of  differential expression was assessed using the empirical 
Bayes moderated paired t statistics (eBayes function) in the 
limma package, followed by intensity-based hierarchical 
Bayes analysis[30,31]. In the analysis, a moderated paired t test 
was computed by constructing cell line effects in the linear 
model. All P values were adjusted for multiple hypotheses 
testing using the bootstrapped q value approach in the 
qvalue package[32]. Genes with P values ≤ 0.05 were identi-
fied as significantly differentially expressed.
The GOrilla Gene Enrichment Analysis and Visualiza-
tion Tool[33] was used to discover functional categories that 
were enriched at either end of  a gene list sorted by the 
moderated t test score, which was calculated using limma. 
The input gene set was used as a background. Clustering 
and visualization of  the gene expression differences were 
done using MeV Multiexperiment Viewer tool and hierar-
chical clustering with Euclidean as a distance, and average 
linkage clustering as the linkage method[34,35].
Quantitative reverse transcriptase-polymerase chain 
reaction
To validate the microarray data, TaqMan® real-time re-
verse transcriptase-polymerase chain reaction (RT-PCR) 
was performed as previously described[22] for selected 
genes. Total RNA from the same samples used for the 
microarray experiments was reverse transcribed to cDNA 
using random hexamers (Invitrogen, Paisley, UK) and Mo-
loney murine leukemia virus reverse transcriptase (Invitro-
gen). TaqMan® Gene Expression assays (Applied Biosys-
tems, Foster City, CA, USA) were chosen for detection of  
IL8 (Hs00174103_m1), CCL2 (Hs00234140_m1), IL10 
(Hs00174086_m1), HRH4 (Hs00222094_m1), FCER1A 
(Hs00758600_m1) and FCER1G (Hs00610227_m1). 
Transcripts for TNF-α  were detected by using sense 
primer 5'-GCTGCACTTTGGAGTGATCG-3', antisense 
primer 5'-GTTTGCTACAACATGGGCTACAG-3' and 
probe 5'-FAM-CCCAGGCAGTCAGATCATCTTCTC-
GA-BHQ1-3'. Samples were analyzed in triplicate. β-Actin 
was used as an endogenous normalization control. Rela-
tive quantification was determined by standard 2-ΔΔCT cal-
culations[36].
RESULTS
Gene expression profiling
In order to explore the effects of  different probiotic 
bacteria or their combination on mast cells, transcrip-
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tional changes of  the bacteria-stimulated mast cells were 
studied using a whole genome microarray. A total of  42 
Affymetrix GeneChip® Human Genome U133 Plus 2.0 
Arrays were used to analyze gene expression profiles 
of  unstimulated mast cells or those stimulated with live 
LGG, Lc705, PJS, Bb12, or the combination of  these four 
bacteria. Cpn was included in the analysis as a reference 
bacterium, which represented a non-probiotic, pathogenic 
microbe with certain known transcriptional effects on 
mast cells[22]. Results are representative of  three indepen-
dent experiments, each performed with cells from three 
donors at two different time points (3 and 24 h). After 
3 h bacterial stimulation, the differences in the levels of  
mast-cell gene expression were so low that no statistical 
significance was observed as compared to unstimulated 
samples (data not shown). At 24 h, however, a statistically 
significant change was observed in 698 genes. Numbers 
of  differentially expressed genes are illustrated in Figure 1. 
Lc705, LGG and the combination of  the four probiotic 
strains were the most effective stimulators. Bb12 affected 
the expression of  only one gene, and PJS and Cpn failed 
to change mast-cell gene expression significantly. Lc705 
affected mast-cell gene expression the most by changing 
the expression of  629 genes significantly. Of  these genes, 
288 were upregulated and 341 were downregulated. LGG 
altered the expression of  345 genes (160 upregulated and 
185 downregulated), and the combination of  the four 
probiotic strains changed the expression of  91 genes (57 
upregulated and 34 downregulated). Raw data of  the mi-
croarray analysis are available at http://ekhidna.biocenter.
helsinki.fi/poxo/download_data. 
Gene functional category analysis and hierarchical 
clustering
To characterize the biological significance of  the differen-
tially expressed mast-cell genes, a gene ontology category 
analysis was performed. GOrilla Gene Enrichment Analy-
sis and Visualization Tool[33] was used to discover whether 
some functional categories showed statistically significant, 
concordant differences between the stimulated sample 
and the unstimulated sample. The enrichment analyzes 
were carried out for the whole array gene set, including 
the genes that did not reach statistical significance in the 
array analysis, that were ranked based on their moderated 
t values. For the analysis, the ranked genes were sorted in 
the order of  the highest and lowest t value of  each sample. 
The analysis software used the sorted gene lists to classify 
the genes of  each sample into gene ontology categories[37] 
by their biological function. Selected functional groups 
and examples of  genes that represented each category are 
depicted in Table 1. 
Stimulation of  mast cells with LGG, Lc705, Bb12, 
combination of  probiotics, or Cpn resulted in upregula-
tion of  genes that belong to categories that involve im-
mune system processes, regulation of  programmed cell 
death, and leukocyte activation. Stimulation with LGG, 
Lc705, Bb12 or the combination of  probiotics suppressed 
mast-cell genes that are involved in general cell activities 
and metabolism such as cell cycle and lipid biosynthetic 
processes. Lc705 was found to suppress genes that are re-
lated to mast-cell activation. 
Representative genes from the functional categoriza-
tion (Table 1) were selected to compare the expression 
patterns of  different samples. Mast cells have a central role 
in many inflammatory responses as well as in allergy, there-
fore, immunologically relevant genes and genes involved in 
mast cell activation and mediator release were selected. In 
order to compare the expression of  the selected genes, a 
hierarchical comparison analysis with the MeV two-way hi-
erarchical clustering method was performed. As expected, 
LGG and Lc705 but also the combination of  four probi-
otics showed similar expression patterns in the clustering 
analysis, and were therefore considered to alter mast-cell 
gene expression in a similar manner (Figure 2). Genes that 
are involved in similar processes were also grouped: genes 
that encode Toll-like receptor (TLR) 1, nucleotide-binding 
oligomerization domain containing 2 (NOD2), FCER1A 
and FCER1G (high-affinity IgE receptor 1 gene subunits 
α and γ, respectively) grouped together; and genes that en-
code proteins with inflammatory functions, such as IL-1β 
and IL-8 constituted another distinct cluster. 
Although there were differences in the intensity of  the 
expression levels, all bacteria except PJS induced upregula-
tion of  mast-cell genes included in the functional group 
of  immune system regulation. Examples of  upregulated 
genes in this category were TLR1, TLR6, NOD2, IL1B, 
IL8, chemokine (C-C motif) 2 (CCL2), TNF and IL10. 
Genes that are involved in regulation of  programmed 
cell death, such as caspases 3 and 8 (CASP3 and CASP8) 
and cyclin-dependent kinase inhibitor 1B (CDKN1B), 
were observed to be upregulated in LGG, Lc705, and the 
combination-stimulated cells. LGG, Lc705 and the com-
bination also significantly enhanced the expression of  the 
cluster of  differentiation 8 A (CD8A) and lymphocyte 
cytosolic protein 2 (LPC2) genes, which are involved in 
leukocyte activation. 
Cyclin A2 (CCNA2) and mitogen-activated protein ki-
nase 12 (MAPK12) genes involved in the regulation of  cell 
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Figure 1  Schematic representation of statistically significant changes (P 
< 0.05) in mast-cell gene expression after 24 h stimulation with Lactobacil-
lus rhamnosus Lc705, Lactobacillus rhamnosus GG and the combination 
of four probiotic bacteria. LGG: Lactobacillus rhamnosus GG; Lc705: Lacto-
bacillus rhamnosus Lc705.
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cycle, and the latter also in IgE receptor signaling, were ob-
served to be downregulated in cells stimulated with LGG, 
Lc705, and the combination of  four probiotics. Stimulation 
of  mast cells with Lc705 significantly suppressed the ex-
pression of  FCER1A and FCER1G genes. The same trend 
was also observed after stimulation with LGG and the 
combination, although these changes in the analysis failed 
to reach statistical significance. Bb12 was found to suppress 
the expression of  LPGAT1 (lysophosphatidylglycerol ac-
yltransferase 1), a mast cell gene that is related to lipid bio-
synthesis, and also the other bacteria studied had a similar 
impact on the expression of  this gene. 
Manual screening of the array data
To gain further insight into the probiotic-induced changes 
in mast-cell activation, the array data set was screened for 
additional genes that were related to the IgE receptor sig-
naling pathway and mast-cell activation and immunomod-
ulation. The screening was performed manually using the 
list of  genes that reached statistical difference in the array 
analysis at the 24-h time point (http://ekhidna.biocenter.
helsinki.fi/poxo/download_data). The gene that encodes 
phospholipase C (PLC) that is involved in the mast-cell 
IgE receptor signaling pathway was observed to be signifi-
cantly downregulated by LGG and Lc705. The gene that 
encodes prostaglandin E2 receptor (PTGER), which me-
diates the effects of  this inflammatory prostaglandin, was 
also downregulated by LGG and Lc705. Although only 
Lc705 was categorized in the functional group as down-
regulating mast-cell activation, LGG-stimulated cells also 
reached statistical significance in suppressing FCER1A 
expression in the microarray analysis. Both Lc705 and 
LGG also suppressed the expression of  the gene that en-
codes mast-cell histamine H4 receptor (HRH4). Expres-
sion alterations of  the genes that encode the end-products 
of  the IgE receptor signaling pathway were also screened, 
but no changes were observed in the mast-cell expression 
of  leukotrienes, heparin or Th2 type cytokines, such as 
IL-3, IL-4, IL-5 and IL-15 after bacterial stimulation. 
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Table 1  Representative subsets of differentially expressed mast-cell genes after bacterial stimulation classified into functional categories
Go class Description P  value Gene examples
LGG Lc705 PJS Bb12 Combination Cpn
Upregulation
   GO:0002376 Immune system process 3.48E-16 2.95E-13 - 5.25E-7 5.66E-12 1.64E-4 TNF, IL1B, IL8, IL10, CCL2, 
TLR1, TLR6, NOD2
   GO:0043067 Regulation of programmed cell death 2.77E-8 9.63E-8 - 7.18E-4 3.49E-6 - CASP3, CASP8, CDKN1
   GO:0045321 Leukocyte activation 8.97E-9 2.17E-4 - - 2.23E-4 - CD8A, LCP2
Downregulation
   GO:0007049 Cell cycle 4.76E-5 9.61E-7 - - 5.81E-4 - CCNA2, MAPK12
   GO:0033033 Regulation of mast cell activation - 7.51E-4 - - - - FCER1A, FCER1G
   GO:0008610 Lipid biosynthetic process - - - 2.02E-5 - - LPGAT1
The three selected highly upregulated or downregulated functional categories from the enrichment analysis performed with GOrilla Gene Enrichment 
Analysis and Visualization Tool. P value is the enrichment P value reported by GOrilla. The resultant categories reflect the gene expression differences of 
the bacteria-stimulated sample compared to unstimulated sample in 24 h time point. LGG: Lactobacillus rhamnosus GG; Lc705: Lactobacillus rhamnosus Lc705; 
PJS: Propionibacterium freudenreichii ssp. shermanii JS; Bb12: Bifidobacterium animalis ssp. lactis Bb12; Cpn: Chlamydia pneumoniae isolate Kajaani 6; TNF: Tumor 
necrosis factor; IL-1B: Interleukin-1β; IL-8: Interleukin-8; IL-10: Interleukin-10; CCL2: Chemokine (C-C motif) 2; TLR1: Toll-Like receptor 1; TLR6: Toll-Like 
receptor 6; NOD2: Nucleotide-binding oligomerization domain-containing protein 2; CASP3: Caspase 3; CASP8: Caspase 8; CDKN1: Cyclin-dependent kinase 
inhibitor 1; CD8A: Cluster of differentiation 8 A (T cell surface glycoprotein); LCP2: Lymphocyte cytosolic protein 2; CCNA2: Cyclin A2; MAPK12: Mitogen-
activated protein kinase 12; FCER1A: Fc fragment of IgE high affinity I receptor for α polypeptide; FCER1G: Fc fragment of IgE high affinity I receptor for γ 
polypeptide; LPGAT1: Lysophosphatidylglycerol acyltransferase 1.
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Figure 2  Two-way hierarchical clustering of representative genes selected 
from the functional category analysis (Table 1). Data are average expression 
differences between unstimulated and bacteria-stimulated mast cells from three 
independent experiments at the 24-h time point. Analysis was performed using 
MeV software. PJS: Propionibacterium freudenreichii ssp. shermanii JS; Bb12: 
Bifidobacterium animalis ssp. lactis Bb12; Cpn: Chlamydia pneumoniae isolate 
Kajaani 6; Lc705: Lactobacillus rhamnosus Lc705; LGG: Lactobacillus rham-
nosus GG; TLR1: Toll-Like receptor 1; NOD2: Nucleotide-binding oligomerization 
domain-containing protein 2; IL-1B: Interleukin-1β; IL-8: Interleukin-8; TNF: Tumor 
necrosis factor; IL-10: Interleukin-10; CDKN1B: Cyclin-dependent kinase inhibitor 
1B; TLR6: Toll-Like receptor 6; CASP3: Caspase 3; CASP8: Caspase 8; CCL2: 
Chemokine (C-C motif) 2; CD8A: Cluster of differentiation 8 A (T cell surface gly-
coprotein); LCP2: Lymphocyte cytosolic protein 2; CCNA2: Cyclin A2; MAPK12: 
Mitogen-activated protein kinase 12; FCER1A: Fc fragment of IgE high affinity I 
receptor for α polypeptide; FCER1G: Fc fragment of IgE high affinity I receptor for 
γ polypeptide; LPGAT1: Lysophosphatidylglycerol acyltransferase 1.
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Quantitative RT-PCR
Findings from the microarray analysis were verified by 
quantitative RT-PCR. Seven genes with statistical signifi-
cance after 24 h stimulation with at least one of  the bacte-
ria in the array analysis or in the functional categorization 
analysis were selected. Four of  the genes encoded proteins 
that are involved in mast-cell regulation of  immunological 
events: IL8, TNF-α , CCL2 and IL10 (Figure 3A). Three 
of  the genes encoded proteins that are involved in mast-
cell activation and in allergy: FCER1A, FCER1G and 
HRH4 (Figure 3B). With minor differences in the levels 
of  intensities, all of  the selected genes followed a similar 
expression pattern detected in the microarray analysis, and 
thus confirmed the results of  the microarray data. 
DISCUSSION
In the present study, microarray analysis was used to gain 
a broad understanding of  interactions between probiotic 
bacteria and human primary mast cells. We report here, 
that live probiotic bacteria have species-specific effects on 
human mast cells. The most significant changes in mast-
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Figure 3  Verification of mast-cell microarray results by quantitative reverse transcriptase-polymerase chain reaction with seven selected genes that are 
involved in mast-cell immune system regulation (A) and mast-cell activation (B). Gene expression was quantified after 24 h stimulation with four probiotic bacte-
ria; Lactobacillus rhamnosus GG (LGG), Lactobacillus rhamnosus Lc705 (Lc705), Propionibacterium freudenreichii ssp. shermanii JS (PJS), Bifidobacterium animalis 
ssp. lactis Bb12 (Bb12) and their combination or with Chlamydia pneumoniae isolate Kajaani 6 (Cpn). Data are mean values ± SE of three independent experiments. 
IL: Interleukin; TNF-α: Tumor necrosis factor-α; CCL2: Chemokine (C-C motif) 2; FCER1A: Fc fragment of IgE high affinity I receptor for α polypeptide; FCER1G: Fc frag-
ment of IgE high affinity I receptor for γ polypeptide; HRH4: Histamine H4 receptor.
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cell gene expression were observed in the regulation of  
genes related to mast-cell activation and mediator release, 
including FCER1A, FCER1G and HRH4, and immuno-
logical responses such as IL8, TNF, CCL2 and IL10.
In the microarray analysis, lactobacilli affected mast-
cell gene expression more than the other bacteria. Stimu-
lation of  mast cells with both LGG and Lc705 signifi-
cantly downregulated the expression of  the high-affinity 
IgE receptor subtype α (FCER1A) and HRH4 (HRH4) 
genes after 24 h stimulation. In addition, Lc705 stimula-
tion downregulated the gene expression of  FCεR1 recep-
tor subtype γ (FCER1G). PJS, Bb12, the combination, or 
Cpn did not have an effect on FCER1 and HRH4 genes. 
FCεR1 plays a key role in mediating the allergy-related 
IgE-dependent activation and degranulation of  mast 
cells[38] as demonstrated in FCεR1-deficient mice that 
fail to show allergic reactions after sensitization[39]. After 
FCεR1 aggregation, mast cells release inflammatory medi-
ators, such as histamine. Histamine is the key mediator in 
causing the symptoms of  allergy, and it also has a potent 
role as a modulator of  immune responses[40]. The effects 
of  histamine are mediated through histamine receptors 
H1-H4 that are expressed on the surface on many cell 
types, including mast cells and other inflammatory cells 
as well as epithelial cells[41]. The most recently discovered 
HRH4 has been shown to have mainly immunomodula-
tory effects[41]. The expression of  histamine receptors is 
suggested to be influenced by inflammatory stimuli[40]. 
In addition, modification of  histamine receptor gene 
expression is suggested to play a role in the pathogenesis 
of  allergy, atherosclerosis and rheumatoid arthritis[7]. By 
suppressing the expression of  FCER1 and HRH4 genes, 
probiotic lactobacilli could attenuate mast-cell activation 
and release of  allergy-related mediators. 
To obtain more evidence of  the possible ability of  
probiotics to suppress mast-cell activation, the array gene 
set was manually screened for other genes involved in IgE 
receptor signaling. Expression of  the gene that encodes 
PLC, which is involved in the release of  intracellular cal-
cium and in mast-cell degranulation[39], was suppressed 
significantly after Lc705 and LGG stimulation. Addition-
ally, the gene that encodes expression of  the member 
of  the mitogen-activated protein kinase (MAPK) family, 
MAPK12, that participates in the signaling events that lead 
to the production of  Th2 type cytokines IL-3, IL-4, IL-5 
and IL-13, and in the generation of  eicosanoids[38], was 
also downregulated in Lc705 and LGG-stimulated mast 
cells. These findings suggest that Lc705 and LGG have 
an inhibitory effect on mast-cell genes that are involved in 
the IgE signaling cascade, beyond inhibition of  IgE recep-
tor gene expression. 
Our results with human primary mast cells are in 
line with those of  two previous studies of  the effects of  
non-pathogenic bacteria on human or mouse mast cells. 
Escherichia coli (E. coli) K12 strain has been found to down-
regulate FCER1A in the malignant human mast cell line 
(LAD3)[42]. The other study has reported that E. coli strain 
DSM 17252 inhibits mast-cell degranulation in mouse 
peritoneal mast cells[43]. Commensal non-pathogenic E. coli 
and probiotic LGG and Lc705 seem to downregulate 
mast-cell IgE responses similarly. These results suggest 
that commensal and probiotic bacteria do not stimulate 
mast cells but rather diminish their activation. However, it 
is worth noticing that this effect is not universal response 
to bacteria, because not all probiotic bacteria or pathogen-
ic Cpn affected the gene expression of  high-affinity IgE 
receptor similarly. 
Probiotic bacteria were also observed to alter the ex-
pression of  genes that have inflammatory functions. In the 
functional categorization analysis, the expression of  a cate-
gory of  immune system process that contains, for example, 
a gene that encodes an inflammatory mediator that is also 
regulated by the MAPK pathway, TNFα[44], was upregulat-
ed in mast cells stimulated with LGG, Lc705, Bb12 and the 
combination. The categorization analysis also highlighted 
upregulated functions in known inflammatory genes such 
as IL8, CCL2, and IL1B in cells stimulated with LGG, 
Lc705, Bb12 and the combination. The same genes were 
also upregulated in mast cells stimulated with Cpn, which 
is in line with our previous study in which Cpn elicited pro-
inflammatory effects in mast cells[22]. However, no upregu-
lation in any of  the Th2 type cytokine genes in mast cells 
after probiotic stimulation in the gene microarray was ob-
served. In the prevention of  the symptoms in allergic dis-
eases, probiotics have been suggested to elicit low-grade in-
flammation and thus shift the immune response away from 
the allergy-related Th2 type inflammation[45,46]. In in vitro 
studies, probiotic bacteria have been observed to induce 
the secretion and expression of  Th1 type cytokines in 
monocytes, macrophages and dendritic cells[47-49]. Addition-
ally, in a clinical study, low-grade inflammation induced by 
LGG in allergy-prone children has been proposed to be 
one mechanism to prevent atopic diseases[45]. The ability of  
LGG, Lc705, Bb12 and the combination to induce in mast 
cells pro-inflammatory rather than Th2 type cytokine ex-
pression could have contributed to the observed beneficial 
low-grade inflammatory response in the above-cited study. 
Our findings in mast cells support the idea that some pro-
biotic strains shift the mast-cell-mediated immunological 
response from the Th2 to Th1 type, by inducing expres-
sion of  pro-inflammatory mediators. 
Mast cells stimulated with LGG, Lc705, Bb12, the 
combination, or with Cpn also induced the expression 
of  a gene that encodes anti-inflammatory IL-10. Mast-
cell-derived IL-10 has been observed to be crucial in re-
striction of  chronic skin inflammation in hypersensitivity 
reactions[50]. Probiotic Bifidobacterium strains have been ob-
served to stimulate IL-10 production in immune cells[51]. 
IL-10 induction in mast cells could participate in balancing 
the inflammatory impact. In vivo, the combination of  af-
fected genes after bacterial stimulation is likely to be more 
important than a change in the expression of  any single 
gene. Thus, the downregulation of  FCER1 and HRH4 
genes combined with the upregulation of  IL10 after 
stimulation with probiotic Lactobacillus might be involved 
in downregulation of  inflammatory responses in allergy 
and other inflammatory diseases in which mast cells are 
known to a play role, such as atherosclerosis, rheumatoid 
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arthritis, inflammatory bowel disease and IBS[5,52-54]. As 
Cpn upregulated only IL10 without affecting FCER1 and 
HRH4, mast cells stimulated with pathogenic Cpn might 
not have the same clinical effects as those stimulated with 
probiotic bacteria.
In addition to FCεR1 and HRH4, the function of  
mast cells is regulated through a variety of  other receptors, 
such as TLRs. In our previous study, we have shown that 
TLR2 is a receptor for LGG, which triggers the nuclear 
factor-κB signaling cascade, which leads to expression of  
different cytokines in human primary macrophages[55]. In 
addition, probiotic bacteria have been shown to suppress 
mast-cell degranulation by interrupting FCεR1-mediated 
signaling through TLR2[56]. The paradox of  the ability of  
probiotic LGG and Lc705 to diminish mast-cell activa-
tion, but enhance the mast-cell immune response, could 
be regulated through the same receptor, TLR2.
PJS failed to change mast-cell gene expression sig-
nificantly at either time point. Previously, PJS has been 
observed to induce TNFα expression after 3 h stimula-
tion, and IL-10 expression after 3 and 24 h stimulation in 
human peripheral blood mononuclear cells (PBMCs)[24]. 
It could be that mast cells are unresponsive to PJS unlike 
the PBMC population. It could also be that the quantita-
tive spectrum of  microarray is a limiting factor, especially 
if  the expression differences between unstimulated and 
stimulated samples are low or if  the gene is expressed in 
low quantities[57]. In our experiments, the differences in 
the gene expression levels of  the microarrays were rela-
tively low, which is in accordance with other microarray 
studies performed with probiotic bacteria[58]. 
Crosstalk between probiotic bacteria and intestinal 
mast cells is likely to occur mainly through gut epithelial 
cells[59]. Probiotic bacteria or their products could inciden-
tally translocate to the lamina propria through intestinal 
M cells and make direct contact with immunological cells 
such as mast cells. Additionally, mast cells are suggested 
to have the possibility to be in direct contact with bacteria 
or bacterial fragments in atherosclerotic plaques[53,60]. Frag-
ments of  Firmicutes and Proteobacteria, which are prob-
ably of  intestinal origin, as well as Cpn have been detected 
from atherosclerotic plaques[60]. The intestinal barrier 
is believed to leak also in healthy humans, which would 
allow probiotic bacteria to access spaces that contain 
macrophages, dendritic cells and mast cells. Even though 
in vivo evidence of  direct contact between mast cells and 
probiotic bacteria in the human intestine is missing, in vitro 
interaction studies performed with direct contact between 
bacteria and host cells, such as mast cells, are required for 
better understanding of  the molecular basis of  the immu-
nomodulative properties of  probiotic bacteria. 
The mast cells differentiated by the peripheral-blood-
derived isolation method comprise mainly the MCTC phe-
notype[23], whereas the gut contains both MCTC and MCT 
phenotypes; the latter being the predominant mucosal 
mast-cell phenotype[2]. However, the MCT and MCTC phe-
notypes both express high-affinity IgE receptors and pro-
duce a variety of  inflammatory mediators. The responses 
observed in this study could be further evaluated in a 
more physiological context, e.g. in ex vivo culture models 
using mast cells derived from human intestinal tissues, or 
in in vivo animal or clinical studies. 
The present study is believed to be the first to describe 
the effects of  probiotic bacteria on human mast cells. Our 
data suggest that especially probiotic L. rhamnosus Lc705 
and L. rhamnosus GG could diminish mast-cell activation 
and the effects of  allergy-related mediators by down-
regulating expression of  the high-affinity IgE and HRH4 
receptors, and by stimulating mast-cell immune responses. 
Mast cells are important mediators of  allergic responses 
on host surfaces including the intestine, therefore, we pro-
pose that mast cells participate in regulating the beneficial 
immunological responses to probiotic bacteria.
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